HIIFS
IHE icon

Harel Insurance Investments & Financial Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,400
Closed -$113K – 475
2018
Q4 		$113K Buy
+2,400
New +$123K 0.01% 224
2016
Q3 		– Sell
-4,200
Closed -$202K – 571
2016
Q2 		$202K Buy
+4,200
New +$200K 0.02% 158

Other funds holding IHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Harel Insurance Investments & Financial Services's IHE Position: Q1 2019 in Review

Harel Insurance Investments & Financial Services sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2019, closing a stake of 2,400 shares — an estimated $113K sold.

Harel Insurance Investments & Financial Services first reported a position in IHE in Q2 2016 and held it in 2 quarters. The position peaked at $202K in Q2 2016. 91 funds tracked by Wall St. Rank hold IHE as of Q1 2019.

  • Harel Insurance Investments & Financial Services reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 2,400 iShares US Pharmaceuticals ETF shares in Q1 2019, an estimated $113K.
  • Harel Insurance Investments & Financial Services first reported a position in iShares US Pharmaceuticals ETF in Q2 2016 and held it in 2 quarters.
  • Harel Insurance Investments & Financial Services's iShares US Pharmaceuticals ETF position peaked at $202K in Q2 2016.
  • 91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2019.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2019, filed 18 Apr 2019.